CHF-5633

N/A

Report date: 2023/05/24 20:00:35
NME

Base Information

Drug NameCHF-5633
Drug Alias NameCHF-5633
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsRespiratory Distress Syndrome, Newborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Newborn

Other Information

ATC CodeN/A
Related LinksN/A